Soleno Therapeutics Inc (SLNO): Next-Year EPS Estimate 72.91%
As of 2026-05-28, Soleno Therapeutics Inc (SLNO) has a next-year EPS growth estimate of 72.91%. Featured in 2 EPS revision reports, most recently on 2026-04-13.
On 2026-05-24, analyst consensus for SLNO's next-year EPS growth shifted from 60.02% to 72.91% — a positive change of 12.89 percentage points. The revised estimate has been sustained across 5 subsequent trading sessions. Current-year growth is projected at 999.36%.
What's Driving This
Analysts raised SLNO's next-year EPS growth estimate from 60.02% to 72.91% on 2026-05-24, marking the primary structural driver behind the stock's rise. This upgrade reflects a net +13.73 percentage point increase across subsequent revisions, with two upward moves outweighing one downward adjustment. Momentum has continued beyond the initial revision, as the current estimate remains at the elevated 72.91% level. No recent news headlines are available to connect the upgrade to a specific catalyst such as an earnings beat or guidance raise.
Generated 2026-07-31 from news as of 2026-05-28
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 72.91%
- EPS growth this year
- 999.36%
- EPS next quarter (est)
- $0.99
- Last price
- $53.01
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-28 | 72.91% | 999.36% | $0.99 | $53.01 |
| 2026-05-27 | 72.91% | 999.36% | $0.99 | $53.01 |
| 2026-05-26 | 72.91% | 999.36% | $0.99 | $53.01 |
| 2026-05-25 | 72.91% | 999.36% | $0.99 | $53.01 |
| 2026-05-24 | 72.91% | 999.36% | $0.99 | $53.01 |
| 2026-05-21 | 60.02% | 968.80% | $0.96 | $53.01 |
| 2026-05-20 | 61.21% | 877.21% | $0.92 | $53.01 |
| 2026-05-19 | 61.21% | 877.21% | $0.92 | $53.01 |
| 2026-05-18 | 59.18% | 912.39% | $0.94 | $53.01 |
| 2026-05-17 | 59.18% | 912.39% | $0.94 | $53.01 |
| 2026-05-14 | 59.18% | 912.39% | $0.94 | $52.99 |
| 2026-05-13 | 59.18% | 912.39% | $0.94 | $52.97 |
| 2026-05-12 | 59.18% | 912.39% | $0.94 | $52.93 |
| 2026-05-11 | 59.18% | 912.39% | $0.68 | $52.94 |
| 2026-05-10 | 59.18% | 912.39% | $0.68 | $52.95 |
| 2026-05-07 | 59.18% | 912.39% | $0.68 | $52.95 |
| 2026-05-06 | 59.18% | 912.39% | $0.68 | $52.94 |
| 2026-05-05 | 59.18% | 912.39% | $0.68 | $52.92 |
| 2026-05-04 | 59.18% | 912.39% | $0.68 | $52.90 |
| 2026-05-03 | 59.18% | 912.39% | $0.68 | $52.87 |
| 2026-04-30 | 59.18% | 912.39% | $0.68 | $52.82 |
| 2026-04-29 | 59.18% | 912.39% | $0.68 | $52.78 |
| 2026-04-28 | 59.18% | 912.39% | $0.68 | $52.76 |
| 2026-04-27 | 59.18% | 912.39% | $0.68 | $52.75 |
| 2026-04-26 | 59.18% | 912.39% | $0.68 | $52.72 |
| 2026-04-24 | 59.18% | 912.39% | $0.68 | $52.72 |
| 2026-04-23 | 59.18% | 912.39% | $0.68 | $52.83 |
| 2026-04-22 | 59.18% | 912.39% | $0.68 | $52.75 |
| 2026-04-21 | 59.18% | 912.39% | $0.68 | $52.69 |
| 2026-04-20 | 59.18% | 912.39% | $0.68 | $52.67 |
Reports Featuring SLNO
Screen Performance
Aggregate stats across all 1903 tickers our top-EPS-revision screen has flagged over the past 121 days.
- Median return since detection
- +1.2%
- % of tickers in the green
- 52%
- Median return on winners
- +18.8%
- Large revisions captured
- 1198
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Soleno Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-05-28, Soleno Therapeutics Inc (SLNO) has a next-year EPS growth estimate of 72.91%, based on analyst consensus.
When was the latest EPS estimate revision for SLNO?▾
The most recent revision occurred on 2026-05-24, when analysts adjusted the next-year EPS growth estimate from 60.02% to 72.91%.
What sector and industry does Soleno Therapeutics Inc belong to?▾
Soleno Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. SLNO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Soleno Therapeutics Inc (SLNO) appears here because it was detected by our daily top-EPS-revision-performer screen.